Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Greetings, and welcome to TG Therapeutics First Quarter Conference ...

The potentially first-in-class drug, which targets CD20, is able to achieve "deep B-cell depletion" by stimulating cells of the immune system to engulf and destroy B-cells in the presence of a ...

Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS patients on Ocrevus.

Deficiency: If you have a vitamin B12 deficiency you will feel tired or weak, pale skin, loss of appetite, infertility and others. It can also cause balance issue, depression and poor memory.

Updated clinical data in heavily pre-treated, CAR-T naïve patients with B-NHL shows prolonged duration of response, with ...

As a novel calcineurin inhibitor with proven efficacy in improving renal outcomes, LUPKYNIS addresses a high unmet medical need. With increasing awareness, supportive guidelines, and potential ...

It is possible that AtLP represent multiclonal B cells, T cells or NK-cell lymphoproliferative processes in which there is an existence of occult abnormal B-cell, T-cell or NK-cell clones.